RecruitingNCT05437536
Rare condition
Von Willebrand disease type 2A
2
studies recruiting now
as of 7 Sept 2026
3
studies registered in total
as of 7 Sept 2026
3
countries with a recruiting site
as of 7 Sept 2026
24 Sept 2024
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT06610201
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Showing the 2 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Von Willebrand disease type 2A studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Von Willebrand disease type 2A study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Von Willebrand disease type 2A
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (VWF).
Treatments being studied
3 approved treatments and 3 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Von Willebrand Factor Human (Von willebrand factor human component of voncento)Approved: Human Coagulation Factor Viii (Hemofil m)Approved: Vonicog Alfa (Veyvondi)
Phase 3Octocog Alfa (Advate)
Phase 3Tranexamic Acid (Cyklo-f heavy period relief)
Phase 2Rondaptivon Pegol
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).